MX2021010689A - Formulaciones inyectables listas para usar. - Google Patents

Formulaciones inyectables listas para usar.

Info

Publication number
MX2021010689A
MX2021010689A MX2021010689A MX2021010689A MX2021010689A MX 2021010689 A MX2021010689 A MX 2021010689A MX 2021010689 A MX2021010689 A MX 2021010689A MX 2021010689 A MX2021010689 A MX 2021010689A MX 2021010689 A MX2021010689 A MX 2021010689A
Authority
MX
Mexico
Prior art keywords
ready
injectable formulations
use injectable
resuspendability
syringeability
Prior art date
Application number
MX2021010689A
Other languages
English (en)
Inventor
Todd P Foster
Laibin Luo
Vijaya Bharti Joshi
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2021010689A publication Critical patent/MX2021010689A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención describe una composición de cefalosporina inyectable lista para el uso con una viscosidad razonable, capacidad de resuspensión y atributos de capacidad de colocarse en jeringas para la inyección como un antibiótico para animales.
MX2021010689A 2019-03-06 2020-03-05 Formulaciones inyectables listas para usar. MX2021010689A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962814440P 2019-03-06 2019-03-06
PCT/US2020/021060 WO2020181024A1 (en) 2019-03-06 2020-03-05 Ready-to-use injectable formulations

Publications (1)

Publication Number Publication Date
MX2021010689A true MX2021010689A (es) 2021-10-01

Family

ID=70009447

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010689A MX2021010689A (es) 2019-03-06 2020-03-05 Formulaciones inyectables listas para usar.

Country Status (12)

Country Link
US (1) US20220125798A1 (es)
EP (1) EP3934618A1 (es)
JP (1) JP7323630B2 (es)
KR (1) KR102671650B1 (es)
AU (1) AU2020232306B2 (es)
BR (1) BR112021017536A2 (es)
CA (1) CA3132159C (es)
IL (1) IL285520A (es)
MA (1) MA55205A (es)
MX (1) MX2021010689A (es)
WO (1) WO2020181024A1 (es)
ZA (1) ZA202105883B (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557615C2 (de) 1975-12-20 1985-08-14 Bayer Ag, 5090 Leverkusen Neue Niclosamid-Suspensionsformulierungen
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US6911441B2 (en) * 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CN1517090A (zh) * 2003-01-20 2004-08-04 王玉万 含抗菌药物的兽用混悬注射剂或乳剂
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
CN1569000A (zh) * 2003-07-16 2005-01-26 王玉万 含头孢菌素的速效并长效注射剂
EP2367572B1 (en) * 2008-11-19 2018-08-29 Merial, Inc. Formulations comprising ceftiofur and benzyl alcohol
WO2012095438A1 (en) * 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
BR112014014786A2 (pt) * 2011-12-23 2017-06-13 Bayer New Zealand Ltd formulações de antibiótico
ES2740958T3 (es) * 2012-02-27 2020-02-07 Bayer New Zealand Ltd Composiciones de liberación controlada y sus procedimientos de uso
US20130309226A1 (en) * 2012-05-18 2013-11-21 Genentech, Inc. High-concentration monoclonal antibody formulations
CN108578362A (zh) * 2018-05-30 2018-09-28 河北维尔利动物药业集团有限公司 一种头孢维星混悬注射液及其制备方法

Also Published As

Publication number Publication date
EP3934618A1 (en) 2022-01-12
MA55205A (fr) 2022-01-12
NZ779449A (en) 2023-11-24
ZA202105883B (en) 2023-03-29
WO2020181024A1 (en) 2020-09-10
AU2020232306A1 (en) 2021-09-02
CA3132159C (en) 2023-11-21
CA3132159A1 (en) 2020-09-10
AU2020232306B2 (en) 2023-11-16
JP2022523573A (ja) 2022-04-25
BR112021017536A2 (pt) 2021-11-09
US20220125798A1 (en) 2022-04-28
JP7323630B2 (ja) 2023-08-08
IL285520A (en) 2021-09-30
KR102671650B1 (ko) 2024-06-04
KR20210120084A (ko) 2021-10-06

Similar Documents

Publication Publication Date Title
EP3585862A4 (en) BLENDED FUEL COMPOSITIONS WITH IMPROVED EMISSION PROFILES
MX2018005745A (es) Control de niveles redox celulares.
WO2017180480A8 (en) Accurate, precise microliter dosing syringe
EP3890732A4 (en) INJECTABLE FORMULATIONS
EP3968979A4 (en) KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
EP3878928A4 (en) LUBRICANT COMPOSITION
EP3442503A4 (en) INJECTABLE COMPOSITION FOR THE ADMINISTRATION OF A BIOLOGICAL ACTIVE SUBSTANCE
EP3606998A4 (en) LOW-EMISSION POLYOXYMETHYLENE COMPOSITION
EP3793359A4 (en) ANTIMICROBIAL COMPOSITION
EP3946524A4 (en) MOVABLE SLEEVE INJECTION ARRANGEMENT
EP3648739B8 (en) Composition for injection
WO2019222400A3 (en) Mucus-penetrating peptides, delivery vehicles and methods of therapy
EP3866783A4 (en) INTRATUMOR INJECTION FORMULATION
MX2021002787A (es) Composiciones de alimento animal y usos de las mismas.
EP3802479A4 (en) FR COMPOSITIONS WITH DRIPPING ADDITIVES
MX2021010689A (es) Formulaciones inyectables listas para usar.
EP4023292A4 (en) INJECTION FORMULATION
IL281724B (en) Automatic reset of buffered direct reference pixels
EP4007620A4 (en) VARIABLE LENGTH INJECTION SYRINGE
BR112021023274A2 (pt) Formulações de terlipressina
GB201901197D0 (en) G-A Crosslinking cytotoxic agents
EP3863609A4 (en) SMALL POLYMERIC CARRIERS FOR DELIVERY OF ACTIVE INGREDIENTS
EP3858377A4 (en) INJECTABLE COMPOSITION
EP3749716A4 (en) ELASTOMER COMPOSITION
EP3833414A4 (en) MULTIPLE SYRINGE FOR INTRAOCULAR INJECTIONS